DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 1BORTEZOMIB
Reset all filters
01 1206927
Reset all filters
01 1No
Drug : BORTEZOMIB
Dosage Form : POWDER; INTRAVENOUS
Application Number : 206927
Country : US
Patented : No